Iovance Biotherapeutics, Inc.
IOVA
Revenue
49.32M
▼-24.37M▼-33.07%
3 Months ChangeAssets
966.74M
▲56.31M▲6.19%
3 Months ChangeLiabilities
198.88M
▼-1.15M▼-0.5729%
3 Months ChangeFree Cash Flow
-109.91M
▲16.55M▲13.08%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-09
Form 8-K
ID: 0001104659-24-087876
2024-08-08
Form 10-Q
ID: 0001558370-24-011641
2024-08-08
Form 8-K
ID: 0001104659-24-087259
2024-06-28
Form 8-K
ID: 0001104659-24-075997
2024-06-11
Form 8-K
ID: 0001104659-24-070470
2024-06-03
Form 8-K
ID: 0001104659-24-067485
2024-05-24
Form 8-K
ID: 0001104659-24-064825
2024-05-09
Form 10-Q
ID: 0001558370-24-007646
2024-05-09
Form 8-K
ID: 0001104659-24-059322
2024-04-03
Form 8-K
ID: 0001104659-24-043158